Steve Miller Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Steve Miller is Chief Op. & Scientific Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 675,124 shares of CPRX, which is worth approximately $14.8 Million. The most recent transaction as insider was on Aug 20, 2024, when has been sold 150,000 shares (Common Stock, par value $0.001 per share) at a price of $20.35 per share, resulting in proceeds of $3,052,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 675K

18.18% 3M change

1.79% 12M change

Total Value Held $14.8 Million

Steve Miller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2024	SELL Open market or private sale	$3,052,500 $20.35 p/Share	150,000 Reduced 18.18%	675,124 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	13,667 Added 1.63%	825,124 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	14,000 Added 1.7%	811,457 Common Stock, par valu...
Dec 11 2023	BUY Exercise of conversion of derivative security	$169,499 $1.13 p/Share	150,000 Added 15.83%	797,457 Common Stock, par valu...
Dec 05 2023	SELL Open market or private sale	$569,600 $14.24 p/Share	40,000 Reduced 5.82%	647,457 Common Stock, par valu...
May 11 2023	BUY Exercise of conversion of derivative security	$79,000 $0.79 p/Share	100,000 Added 12.7%	687,457 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	13,666 Added 2.27%	587,457 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	20,000 Added 3.37%	573,791 Common Stock, par valu...
Nov 23 2022	SELL Open market or private sale	$346,800 $17.34 p/Share	20,000 Reduced 3.49%	553,791 Common Stock, par valu...
Nov 21 2022	SELL Open market or private sale	$1,222,400 $15.28 p/Share	80,000 Reduced 12.24%	573,791 Common Stock, par valu...
Sep 13 2022	SELL Open market or private sale	$1,833,782 $16.99 p/Share	107,933 Reduced 14.17%	653,791 Common Stock, par valu...
Aug 18 2022	SELL Open market or private sale	$2,025,000 $13.5 p/Share	150,000 Reduced 16.45%	761,724 Common Stock, par valu...
Aug 18 2022	BUY Exercise of conversion of derivative security	$379,500 $2.53 p/Share	150,000 Added 15.9%	793,149 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	20,000 Added 2.56%	761,724 Common Stock, par valu...
Aug 25 2021	SELL Open market or private sale	$444,800 $5.56 p/Share	80,000 Reduced 9.74%	741,724 Common Stock, par valu...
Aug 25 2021	BUY Exercise of conversion of derivative security	$374,400 $3.12 p/Share	120,000 Added 12.74%	821,724 Common Stock, par valu...
Aug 13 2021	SELL Open market or private sale	$249,465 $6.09 p/Share	40,963 Reduced 5.52%	701,724 Common Stock, par valu...
Aug 13 2021	BUY Exercise of conversion of derivative security	$202,800 $3.12 p/Share	65,000 Added 8.05%	742,687 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	20,000 Added 2.87%	677,687 Common Stock, par valu...

Steve Miller

Chief Op. & Scientific Officer

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account